search
FDA
Trends
- 1E. coli outbreak linked to raw milk cheese sickens 13 across US▼E. coli outbreak linked to raw milk cheese leads to 13 illnesses and eight hospitalizations across the US: FDA
US health authorities are investigating an E. coli outbreak tied to raw milk cheese that has sickened 13 people and hospitalized eight, according to the FDA. Cases have been reported across multiple states, and officials are working to identify the specific cheese products involved. Consumers are being cautioned about unpasteurized dairy products, which carry a higher risk of bacterial contamination.
- 2FDA links Ecuadorian black clams to hepatitis A outbreak▼FDA warns black clams from Ecuador tied to hepatitis A outbreak, 30 hospitalized
The FDA has warned that black clams imported from Ecuador are tied to a hepatitis A outbreak in the United States, with 30 people hospitalized. Health officials are urging consumers to avoid the product as the investigation continues. The warning has raised concerns about import screening and food safety oversight of shellfish reaching American markets.
- 3Former FDA chief says cyclosporiasis outbreak not under control●Cyclosporiasis outbreak not 'fully under control,' former FDA chief says
A former FDA commissioner says the ongoing cyclosporiasis outbreak in the United States is not 'fully under control,' raising concerns about the foodborne illness linked to contaminated produce. The intestinal infection, caused by the Cyclospora parasite, typically causes weeks of diarrhea and fatigue. Health officials are continuing to investigate the source as cases are reported across multiple states.
- 4Raw milk cheese recalled over E. coli outbreak▼Raw milk cheese recalled over E. coli outbreak, FDA says
US health regulators have announced a recall of raw milk cheese linked to an ongoing E. coli outbreak, according to the FDA. Outlets including DC News Now, WTNH and NewsNation are reporting the recall, which affects consumers who may have purchased the contaminated cheese. Officials typically urge anyone with the product to discard it and seek medical care if symptoms of E. coli infection develop.
- 5Thyroid Medicine Recall Classified as FDA's Highest Risk●Thyroid medicine recall classified under FDA's highest risk level https:// blog.taursnd.haus/display/1a04 1b09-206a-b7ca
A thyroid medicine has been recalled and the recall has been classified under the FDA's most serious risk level, meaning the agency considers the product potentially capable of causing serious harm or death. The news is circulating among readers discussing medication safety and whether patients taking thyroid medication need to check their supply or consult a doctor.
- 6
Disc Medicine is facing investor investigations following an FDA letter related to one of its drug programs. Law firms have announced probes into whether the biotech company misled shareholders about regulatory prospects. The news has drawn attention from biotech investors watching how the FDA's response could affect the company's clinical development plans and share value.
- 7Arrowhead Pharmaceuticals Stock Nears Five-Year High on Phase 3 Win▼ARWR Stock On Track To Hit Over 5-Year Highs – Retail Cheers Phase 3 Breakthrough As Arrowhead Targets Broader FDA Approval
Arrowhead Pharmaceuticals shares are on track to reach their highest level in more than five years after positive Phase 3 trial results, with retail investors celebrating the biotech's momentum. The company is reportedly aiming for a broader FDA approval than initially expected, fueling optimism about the commercial potential of its drug pipeline and driving renewed interest in the stock.